Strober, B., Gottlieb, A., Tha?i, D., Puig, L., Colombo, M. J., Kundu, S., Kisa, R. and Banerjee, S. (2020) “An Oral, Selective Tyrosine Kinase 2 Inhibitor, BMS-986165, Reduced Absolute Psoriasis Area and Severity Index in a Phase 2 Trial in Psoriasis”, SKIN The Journal of Cutaneous Medicine, 4(5), p. s27. doi: 10.25251/skin.4.supp.27.